Satellos Bioscience Company Executives
| MSCL Stock | 17.01 0.69 4.23% |
Satellos Bioscience employs about 14 people. The company is managed by 14 executives with a total tenure of roughly 33 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Satellos Bioscience's management performance can provide insight into the firm performance.
Satellos |
Satellos Bioscience Management Team Effectiveness
The company has return on total asset (ROA) of (0.5425) % which means that it has lost $0.5425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8759) %, meaning that it generated substantial loss on money invested by shareholders. Satellos Bioscience's management efficiency ratios could be used to measure how well Satellos Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Satellos Bioscience shows a total of 20.63 Million outstanding shares. Satellos Bioscience has 6.2 % of its outstanding shares held by insiders and 6.17 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Satellos Bioscience in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Satellos Bioscience, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Satellos Bioscience Workforce Comparison
Satellos Bioscience is considered to be number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is now estimated at about 2,035. Satellos Bioscience maintains roughly 14.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
Satellos Bioscience Benchmark Summation
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Lowest value over a specified period line plots minimum value of Satellos Bioscience price series.
Satellos Bioscience Notable Stakeholders
A Satellos Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Satellos Bioscience often face trade-offs trying to please all of them. Satellos Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Satellos Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Rudnicki | CoFounder Officer | Profile | |
| Francis MBA | CEO, CoFounder | Profile | |
| William Jarosz | Executive Director | Profile | |
| Michael MBA | Chief Officer | Profile | |
| Philip MA | Chief Officer | Profile | |
| CPA CMA | Head Strategy | Profile | |
| Ryan Mitchell | Senior Development | Profile | |
| Desiree Chan | Chief Staff | Profile | |
| Courtney Wells | Senior Operations | Profile | |
| Jordan MD | Chair Officer | Profile | |
| MS MBA | Chief Affairs | Profile | |
| Robert CFA | Senior Administration | Profile | |
| Bsc BSc | Strategic Advisor | Profile | |
| MPH MD | Chief Officer | Profile |
About Satellos Bioscience Management Performance
The success or failure of an entity such as Satellos Bioscience often depends on how effective the management is. Satellos Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Satellos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Satellos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Satellos Bioscience Workforce Analysis
Traditionally, organizations such as Satellos Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Satellos Bioscience within its industry.Satellos Bioscience Manpower Efficiency
Return on Satellos Bioscience Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2M | |
| Net Loss Per Executive | 2M |
Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.